Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
This research studies protein in tumor samples from patients with non-small cell lung cancer. Finding specific proteins in tumor tissue samples from patients with cancer may help doctors tell what type of lung cancer a patient has and plan better treatment.
Checked against the public recordLast updated Jan 24, 2019 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Alliance for Clinical Trials in Oncology
- Interventions being studied
- Other: laboratory biomarker analysis
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients must have been registered on CALGB-9761 * Stage I disease * Treatment-naive patients * A representative paraffin block of the primary tumor must be available from patients on CALGB-9761 and submitted to the CALGB Pathology Coordinating Office * A separate consent form is not required for this study, as permission for research to be performed on the tissue blocks is included in the consent form for CALGB 9761 * Institutional review board (IRB) review and approval at the institution where the laboratory work will be performed is required
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Alliance for Clinical Trials in OncologyBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 24, 2019. Always confirm current availability with the study team.